bNovate Technologies SA is a Swiss-based startup focused on revolutionizing the field of rapid microbiological monitoring for pharmaceutical and drinking water. The company's slogan, "Rapid and automated online bacteria monitoring in drinking water for SAFE WATER. ANYTIME. ANYWHERE.", embodies its core mission.
Founded in 2011, bNovate Technologies SA has been making significant strides in the Biotechnology, Hardware, Industrial, and Information Technology sectors. The company's innovative approach is centered around the development of robust instruments that aim to set new standards in the industry. Through their proprietary and fully automated industrial flow cytometry technology, they have successfully minimized the time taken for water microbiology results from 3 days to an astonishing 20 minutes.
The company recently secured a Fr.12.00M Series C investment on 20 June 2023, with Emerald Technology Ventures as the lead investor. This investment is a testament to the potential and value of bNovate Technologies SA's offerings in the market.
bNovate Technologies SA's commitment to providing safe water anytime, anywhere, combined with their impressive technological advancements, positions them as a promising player in the industry. Their ability to attract significant investments reflects confidence in their vision and capabilities. With their headquarters in Switzerland, the company is strategically positioned to further its impact on a global scale.
No recent news or press coverage available for bNovate Technologies SA.